Modalis Therapeutics Corporation (4883.T)
JPY 103.0
(-1.9%)
JPY 103.0
(-1.9%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | 40.5 Million | 1.1 Million | 342 Million | 644 Million |
| Cost of Revenue | 731 Thousand | 123.67 Million | - | - | - |
| Gross Profit | -731 Thousand | -83.17 Million | 1.1 Million | 342 Million | 644 Million |
| Operating Expenses | 2.37 Billion | 2.1 Billion | 1.24 Billion | 740.35 Million | 499 Million |
| Selling, General and Administrative Expenses | 267.81 Million | 241.98 Million | 231.02 Million | 208.45 Million | 184 Million |
| Research and Development Expenses | 2.1 Billion | 1.86 Billion | 1 Billion | 531.89 Million | 303 Million |
| Other Expenses | 20 Million | 285.14 Million | 560 Thousand | -19.9 Million | - |
| Cost and Expenses | 2.37 Billion | 2.1 Billion | 1.24 Billion | 740.35 Million | 499 Million |
| Operating Income | -2.37 Billion | -2.06 Billion | -1.23 Billion | -398.35 Million | 157 Million |
| Interest Expense | 4.41 Million | 4.82 Million | 1.09 Million | 16.37 Million | - |
| Income Tax Expense | 1.21 Million | -4.32 Million | -6.46 Million | 8.85 Million | 5 Million |
| Earnings before Tax | -2.39 Billion | -2.7 Billion | -745.41 Million | -439.54 Million | 145 Million |
| Net Income | -2.39 Billion | -2.7 Billion | -738.95 Million | -448.4 Million | 140 Million |
| Earnings Per Share Basic | -77.24 | -92.85 | -25.70 | -17.02 | 5.31 |
| Earnings Per Share Diluted | -77.24 | -92.85 | -25.70 | -17.02 | 5.31 |
| Weighted Average Shares Outstanding | 30.96 Million | 29.1 Million | 28.75 Million | 26.34 Million | 26.34 Million |
| Weighted Average Shares Outstanding (Diluted) | 30.96 Million | 29.1 Million | 28.75 Million | 26.34 Million | 26.34 Million |
| Gross Margin | - | -2.05 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | - | -39.04 | -1045.67 | -1.12 | -0.02 |
| Profit Margin | - | -66.73 | -671.78 | -1.31 | 0.22 |
| EBITDA | -2.37 Billion | -2.58 Billion | -667.54 Million | -381.96 Million | - |
| Earnings Before Tax Margin | - | -50.94 | -1126.77 | -1.16 | 0.24 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 348.86 Million | 490.08 Million | 761.23 Million | 2.37 Billion | 564.64 Million | 530.34 Million |
| Selling, General and Administrative Expenses | 54.95 Million | 67.48 Million | 60.04 Million | - | 69.4 Million | 67.22 Million |
| Research and Development Expenses | 293.91 Million | 422.6 Million | 701.18 Million | - | 495.23 Million | 463.12 Million |
| Other Expenses | 4000.00 | 7000.00 | -600 Thousand | -200 Thousand | 392 Thousand | 7000.00 |
| Cost and Expenses | 348.86 Million | 490.08 Million | 761.23 Million | 2.37 Billion | 564.64 Million | 530.34 Million |
| Operating Income | -348.86 Million | -490.08 Million | -761.23 Million | -2.37 Billion | -564.64 Million | -530.34 Million |
| Interest Expense | 1.02 Million | 1.03 Million | 1.08 Million | 4.41 Million | 1.11 Million | 1.1 Million |
| Income Tax Expense | 303 Thousand | 303 Thousand | 302 Thousand | 1.21 Million | 304 Thousand | 303 Thousand |
| Earnings before Tax | -322.7 Million | -457.63 Million | -809.7 Million | -2.39 Billion | -548.27 Million | -500.55 Million |
| Net Income | -323.01 Million | -457.93 Million | -810.01 Million | -2.39 Billion | -548.58 Million | -500.85 Million |
| Earnings Per Share Basic | -8.41 | -13.57 | -24.47 | - | -17.58 | -16.84 |
| Earnings Per Share Diluted | -8.41 | -13.57 | -24.47 | - | -17.58 | -16.84 |
| Weighted Average Shares Outstanding | 38.4 Million | 33.74 Million | 33.1 Million | 33.42 Million | 31.19 Million | 29.74 Million |
| Weighted Average Shares Outstanding (Diluted) | 38.4 Million | 33.74 Million | 33.1 Million | 33.42 Million | 31.19 Million | 29.74 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -348.86 Million | -456.41 Million | -807.82 Million | - | -546.28 Million | -484.46 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
0821
MRTN
TITANSEC
TEXMOPIPES
SRPL
4725